Denosumab 60mg Injection
Description
Denosumab 60mg Injection is a prescription biological medicine containing denosumab as its active ingredient. It belongs to a class of medicines known as RANK ligand (RANKL) inhibitors and is primarily used in the management of osteoporosis and certain conditions associated with bone loss. Denosumab works by reducing the activity of osteoclasts, the cells responsible for breaking down bone tissue.
Cordium Pharmaceuticals Pvt Ltd is a pharmaceutical supplier, distributor and exporter from India, supporting international pharmaceutical procurement enquiries for Denosumab 60mg Injection, subject to product availability and applicable regulatory requirements.
Denosumab 60mg Injection – Product Information
Denosumab 60mg Injection is generally available as a 60mg/1mL solution in a pre-filled syringe, depending on the manufacturer and product presentation. It is administered through a subcutaneous injection by a qualified healthcare professional.
The medicine works by inhibiting RANKL, a protein involved in the formation, function and survival of osteoclasts. By reducing osteoclast activity, denosumab helps decrease bone resorption and supports the maintenance of bone mineral density.
Uses and Medical Applications of Denosumab 60mg
Healthcare professionals may prescribe Denosumab 60mg Injection for specific bone-related conditions, including:
Postmenopausal Osteoporosis: Helps reduce fracture risk in postmenopausal women with osteoporosis who meet the relevant treatment criteria.
Osteoporosis in Men: Used in men with osteoporosis who have an increased risk of fractures.
Glucocorticoid-Induced Osteoporosis: Used in eligible adults experiencing increased fracture risk associated with long-term systemic corticosteroid treatment.
Treatment-Associated Bone Loss: May be prescribed to eligible patients experiencing bone loss associated with hormone-related cancer treatments, according to approved product indications.
Treatment suitability should always be determined by a qualified healthcare professional following an individual medical assessment.
Dosage and Administration
The commonly recommended dosage for the 60mg osteoporosis formulation is one subcutaneous injection every six months. The injection is generally administered into the upper arm, thigh or abdomen by a healthcare professional.
Patients may require calcium and vitamin D supplementation during treatment. Calcium levels and kidney-related risk factors should be evaluated as clinically appropriate. Patients should not change their injection schedule or discontinue treatment without consulting their treating physician.
Important: Denosumab 60mg and Denosumab 120mg are different dosage presentations with different approved indications and treatment schedules. They should not be considered interchangeable.
Side Effects and Safety Precautions
Some patients may experience side effects while receiving Denosumab 60mg Injection. Commonly reported reactions include:
Musculoskeletal pain and back pain
Joint discomfort
Pain in the extremities
Skin reactions, including rashes
Urinary tract infections
Important safety considerations include hypocalcaemia (low blood calcium levels), serious infections, osteonecrosis of the jaw and atypical femoral fractures. Patients with advanced chronic kidney disease may have an increased risk of severe hypocalcaemia.
Existing hypocalcaemia must be corrected before treatment. Dental assessment may be appropriate for patients with relevant risk factors. Treatment decisions, monitoring and discontinuation should remain under medical supervision.
Storage and Handling Information
Denosumab injection should be stored according to the specific manufacturer's approved product information. Refrigerated storage at 2°C–8°C is generally required. Protect the product from light and do not freeze. Follow the manufacturer's instructions regarding handling and any permitted period at room temperature.
Denosumab 60mg Injection Supplier, Distributor and Exporter from India
Cordium Pharmaceuticals Pvt Ltd facilitates pharmaceutical supply and export enquiries for international buyers seeking Denosumab 60mg Injection. We support procurement enquiries from pharmaceutical distributors, importers, hospitals and authorised healthcare procurement organisations.
Our team can assist with product availability enquiries, manufacturer and packaging details, applicable export documentation and international supply coordination, subject to destination-country regulations and import permissions.
For bulk pharmaceutical procurement or international export enquiries, buyers can contact Cordium Pharmaceuticals Pvt Ltd to request product specifications, availability information and a quotation.
